These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 4056258)

  • 41. Late and immediate systemic-allergic reactions to inhalant allergen immunotherapy.
    Greenberg MA; Kaufman CR; Gonzalez GE; Rosenblatt CD; Smith LJ; Summers RJ
    J Allergy Clin Immunol; 1986 Jun; 77(6):865-70. PubMed ID: 3711554
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Inhibition of the late phase reaction to anti-IgE by previous mast cell activation with compound 48/80.
    Grönneberg R
    Allergy; 1984 Feb; 39(2):119-23. PubMed ID: 6608283
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Serum concentrations of allergen-specific IgG antibodies in inhalant allergy: effect of specific immunotherapy.
    Ali M; Ramanarayanan MP; Nalebuff DJ; Fadal RG; Willoughby JW
    Am J Clin Pathol; 1983 Sep; 80(3):290-9. PubMed ID: 6349330
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Airway provocation test with ragweed pollen extract in Chinese asthmatics.
    Lu D; Zhau P; Yu Q; Zhang C
    Asian Pac J Allergy Immunol; 1994 Dec; 12(2):125-9. PubMed ID: 7612105
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Allergic rhinitis to ragweed pollen. II. Modulation of histamine-releasing factor production by specific immunotherapy.
    Brunet C; Bédard PM; Lavoie A; Jobin M; Hébert J
    J Allergy Clin Immunol; 1992 Jan; 89(1 Pt 1):87-94. PubMed ID: 1370511
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Comparison of inflammatory events during developing immunoglobulin E-mediated late-phase reactions and delayed-hypersensitivity reactions.
    Zweiman B; Moskovitz AR; von Allmen C
    Clin Diagn Lab Immunol; 1998 Jul; 5(4):574-7. PubMed ID: 9665969
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Placebo-controlled immunotherapy with Cocos nucifera pollen extract.
    Karmakar PR; Das A; Chatterjee BP
    Int Arch Allergy Immunol; 1994; 103(2):194-201. PubMed ID: 8292907
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Human immunoglobulin E and immunoglobulin G antibody responses to the "minor" ragweed allergen Ra3: correlation with skin tests and comparison with other allergens.
    Platts-Mills TA; Chapman MD; Marsh DG
    J Allergy Clin Immunol; 1981 Feb; 67(2):129-34. PubMed ID: 7451780
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Correlation between lymphocyte responses and immediate hypersensitivity to purified allergens.
    Black PL; Marsh DG
    J Allergy Clin Immunol; 1980 Nov; 66(5):394-401. PubMed ID: 7440857
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Identification of common allergenic structures in mugwort and ragweed pollen.
    Hirschwehr R; Heppner C; Spitzauer S; Sperr WR; Valent P; Berger U; Horak F; Jäger S; Kraft D; Valenta R
    J Allergy Clin Immunol; 1998 Feb; 101(2 Pt 1):196-206. PubMed ID: 9500752
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Combination of passive and active immunization in honeybee venom immunotherapy.
    Bousquet J; Fontez A; Aznar R; Robinet-Levy M; Michel FB
    J Allergy Clin Immunol; 1987 Jun; 79(6):947-54. PubMed ID: 3584749
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Bee venom anti-idiotypic antibody is associated with protection in beekeepers and bee sting-sensitive patients receiving immunotherapy against allergic reactions.
    Khan RH; Szewczuk MR; Day JH
    J Allergy Clin Immunol; 1991 Aug; 88(2):199-208. PubMed ID: 1880320
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Diagnostic problems before specific immunotherapy in patients with late-summer seasonal allergic rhinitis].
    Kadocsa E
    Orv Hetil; 1994 Sep; 135(36):1963-6. PubMed ID: 7936601
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Evaluation of serum IgG4 antibodies specific to grass pollen allergen components in the follow up of allergic patients undergoing subcutaneous and sublingual immunotherapy.
    Rossi RE; Monasterolo G; Coco G; Silvestro L; Operti D
    Vaccine; 2007 Jan; 25(5):957-64. PubMed ID: 17045368
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Efficacy and safety of oral immunotherapy with short ragweed extract.
    Van Deusen MA; Angelini BL; Cordoro KM; Seiler BA; Wood L; Skoner DP
    Ann Allergy Asthma Immunol; 1997 Jun; 78(6):573-80. PubMed ID: 9207721
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Eosinophil activation and T lymphocyte infiltration in allergen-induced late phase skin reactions and classical delayed-type hypersensitivity.
    Gaga M; Frew AJ; Varney VA; Kay AB
    J Immunol; 1991 Aug; 147(3):816-22. PubMed ID: 1830598
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Allergenic cross-reactivity between Parthenium and ragweed pollen allergens.
    Sriramarao P; Rao PV
    Int Arch Allergy Immunol; 1993; 100(1):79-85. PubMed ID: 8428168
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The relationships between late cutaneous responses and specific antibody responses with outcome of immunotherapy for seasonal allergic rhinitis.
    Parker WA; Whisman BA; Apaliski SJ; Reid MJ
    J Allergy Clin Immunol; 1989 Nov; 84(5 Pt 1):667-77. PubMed ID: 2809024
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Quantitative IgE- and IgG-subclass responses during and after long-term ragweed immunotherapy.
    Peng ZK; Naclerio RM; Norman PS; Adkinson NF
    J Allergy Clin Immunol; 1992 Feb; 89(2):519-29. PubMed ID: 1740582
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Artemisia and Ambrosia hypersensitivity: co-sensitization or co-recognition?
    Asero R; Wopfner N; Gruber P; Gadermaier G; Ferreira F
    Clin Exp Allergy; 2006 May; 36(5):658-65. PubMed ID: 16650052
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.